TABLE OF CONTENTS
1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 OVERVIEW OF THE ASIA PACIFIC IMPLANTABLE PORTS MARKET 13
1.4 CURRENCY AND PRICING 14
1.5 LIMITATIONS 14
1.6 MARKETS COVERED 14
2 MARKET SEGMENTATION 16
2.1 MARKETS COVERED 16
2.2 GEOGRAPHICAL SCOPE 17
2.3 YEARS CONSIDERED FOR THE STUDY 18
2.4 DBMR TRIPOD DATA VALIDATION MODEL 19
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 22
2.6 MULTIVARIATE MODELLING 23
2.7 TYPE SEGMENT LIFELINE CURVE 23
2.8 MARKET END USERS COVERAGE GRID 24
2.9 DBMR MARKET POSITION GRID 25
2.10 VENDOR SHARE ANALYSIS 26
2.11 SECONDARY SOURCES 27
2.12 ASSUMPTIONS 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 30
4.1 CONSUMER BUYING BEHAVIOUR 33
4.2 FACTORS AFFECTING BUYING DECISION 33
4.3 PRODUCT ADOPTION SCENARIO 33
4.4 REGULATION COVERAGE 34
4.5 BRAND ANALYSIS 36
4.6 RAW MATERIAL SOURCING ANALYSIS 37
4.7 IMPORT EXPORT SCENARIO 37
4.8 PORTER’S 5 FORCES 39
5 SUPPLY CHAIN ANALYSIS 40
5.1 LOGISTIC COSTS SCENARIO 40
5.2 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS 40
6 MARKET OVERVIEW 42
6.1 DRIVERS 44
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 44
6.1.2 GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 44
6.1.3 INCREASING ONCOLOGY AND CHEMOTHERAPY PROCEDURES 45
6.1.4 IMPROVED DEVICE DESIGN AND FUNCTIONALITY 45
6.2 RESTRAINTS 46
6.2.1 RISK OF INFECTIONS AND MECHANICAL COMPLICATIONS 46
6.2.2 STRINGENT REGULATORY REQUIREMENTS FOR APPROVAL PROCESS 46
6.3 OPPORTUNITIES 47
6.3.1 RISING DEMAND FOR IMPLANTABLE PORT DEVICES DUE TO HIGH SUCCESS RATE 47
6.3.2 EXPANSION OF HOME-BASED HEALTHCARE 47
6.4 CHALLENGES 48
6.4.1 LACK OF SKILLED PROFESSIONALS OR EXPERTISE 48
6.4.2 PRODUCT RECALL OF IMPLANTABLE PORT DEVICES 48
7 ASIA PACIFIC IMPLANTABLE PORTS MARKET, BY TYPE 50
7.1 OVERVIEW 51
7.2 SINGLE LUMEN 54
7.3 DOUBLE LUMEN 54
7.4 POWER- INJECTABLE 55
8 ASIA PACIFIC IMPLANTABLE PORTS MARKET, BY MATERIAL 56
8.1 OVERVIEW 57
8.2 POLYURETHANE 60
8.3 SILICONE 60
8.4 TITANIUM 61
8.5 OTHERS 62
9 ASIA PACIFIC IMPLANTABLE PORTS MARKET, BY APPLICATION 63
9.1 OVERVIEW 64
9.2 CHEMOTHERAPY 67
9.3 BLOOD TRANSFUSION 67
9.4 ANTIBIOTICS 68
9.5 INTRAVENOUS INFUSION OF BLOOD PRODUCT 69
9.6 PAIN MANAGEMENT 69
9.7 OTHERS 70
10 ASIA PACIFIC IMPLANTABLE PORTS MARKET, BY END USERS 71
10.1 OVERVIEW 72
10.2 HOSPITALS 75
10.3 CLINICS 75
10.4 AMBULATORY SURGICAL CENTER 76
10.5 DIALYSIS CENTER 76
10.6 OTHERS 78
11 ASIA PACIFIC IMPLANTABLE PORTS MARKET, BY REGION 79
11.1 ASIA-PACIFIC 80
11.1.1 CHINA 86
11.1.2 JAPAN 88
11.1.3 INDIA 90
11.1.4 AUSTRALIA & NEW ZEALAND 92
11.1.5 SOUTH KOREA 94
11.1.6 INDONESIA 96
11.1.7 PHILIPPINES 98
11.1.8 THAILAND 100
11.1.9 MALAYSIA 102
11.1.10 SINGAPORE 104
11.1.11 REST OF ASIA-PACIFIC 106
12 ASIA PACIFIC IMPLANTABLE PORTS MARKET: COMPANY LANDSCAPE 107
12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 107
13 SWOT 108
14 ASIA PACIFIC IMPLANTABLE PORTS MARKET, COMPANY PROFILE 109
14.1 B.BRAUN SE 109
14.1.1 COMPANY SNAPSHOT 109
14.1.2 COMPANY SHARE ANALYSIS 109
14.1.3 PRODUCT PORTFOLIO 110
14.1.4 RECENT DEVELOPMENTS 110
14.2 ANGIODYNAMICS 111
14.2.1 COMPANY SNAPSHOT 111
14.2.2 REVENUE ANALYSIS 111
14.2.3 COMPANY SHARE ANALYSIS 112
14.2.4 PRODUCT PORTFOLIO 112
14.2.5 RECENT DEVELOPMENT 112
14.3 BD 113
14.3.1 COMPANY SNAPSHOT 113
14.3.2 REVENUE ANALYSIS 113
14.3.3 COMPANY SHARE ANALYSIS 114
14.3.4 PRODUCT PORTFOLIO 114
14.3.5 RECENT DEVELOPMENT 114
14.4 TELEFLEX INCORPORATED 115
14.4.1 COMPANY SNAPSHOT 115
14.4.2 REVENUE ANALYSIS 115
14.4.3 COMPANY SHARE ANALYSIS 116
14.4.4 PRODUCT PORTFOLIO 116
14.4.5 RECENT DEVELOPMENTS 116
14.5 VYGON 117
14.5.1 COMPANY SNAPSHOT 117
14.5.2 COMPANY SHARE ANALYSIS 117
14.5.3 PRODUCT PORTFOLIO 118
14.5.4 RECENT DEVELOPMENT 118
14.6 AMI GMBH 119
14.6.1 COMPANY SNAPSHOT 119
14.6.2 PRODUCT PORTFOLIO 119
14.6.3 RECENT DEVELOPMENT 119
14.7 DISTRICLASS MÉDICAL 120
14.7.1 COMPANY SNAPSHOT 120
14.7.2 PRODUCT PORTFOLIO 120
14.7.3 RECENT DEVELOPMENT 120
14.8 ICU MEDICAL, INC. 121
14.8.1 COMPANY SNAPSHOT 121
14.8.2 REVENUE ANALYSIS 121
14.8.3 PRODUCT PORTFOLIO 122
14.8.4 RECENT DEVELOPMENT 122
14.9 PAKUMEDMEDICAL PRODUCTS GMBH 123
14.9.1 COMPANY SNAPSHOT 123
14.9.2 PRODUCT PORTFOLIO 123
14.9.3 RECENT DEVELOPMENTS 123
15 QUESTIONNAIRE 124
16 RELATED REPORTS 127
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
